Office of New Animal Drug Evaluation
On September 26, 2024, the FDA’s Center for Veterinary Medicine announced the reorganization of the Office of New Animal Drug Evaluation into two separate offices that will handle pre-market evaluation of originator animal products and generic drugs. The reorganization implementation is effective as of October 20, 2024.
We are in the process of updating FDA.gov content to reflect the transition from ONADE to the Office of New Animal Product Evaluation (directory) and the Office of Generic Animal Drugs (directory).
To learn more about the two new offices, click and bookmark the links below: